Solebury Trout
Trout Updates: Solebury Trout October Sell-Side Update
Solebury Trout

Seven IPOs that hit the market in September saw their sell-side coverage begin this month, with all but one analyst assigning a “buy” or equivalent rating to the companies. There was moderate analyst turnover, with new names appearing at banks such as Leerink, UBS, Deutsche Bank and more. Long-time healthcare analyst Tim Anderson, who joined Wolfe Research earlier this year, released his reports on the major pharmaceutical companies. Additionally, Whitney Ijem of Guggenheim initiated coverage of important players in the gene therapy space and Daniel Brennan of UBS released his views of companies in the diagnostics, CROs and CDMO sub-sectors.

Report can be found here